Managed Account Services’s TherapeuticsMD TXMD Stock Holding History

Managed Account Services’s Portfolio TXMD Stock Details TXMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	$15K	Hold	392	–	–	﹤0.01%	106
2021 Q2	$23K	Hold	392	–	–	0.01%	110
2021 Q1	$26K	Buy	392 +50	+15%	+$3.91K	0.01%	103
2020 Q4	$24K	Hold	342	–	–	0.01%	107
2020 Q3	$25K	Hold	342	–	–	0.01%	96
2020 Q2	$36K	Sell	342 -40	-10%	-$2.33K	0.01%	93
2020 Q1	$18K	Sell	382 -29	-7%	-$2.88K	0.01%	86
2019 Q4	$47K	Sell	411 -1	-0.2%	-$144	0.02%	87
2019 Q3	$79K	Sell	412 -32	-7%	-$4.51K	0.04%	85
2019 Q2	$61K	Buy	444 +43	+11%	+$7.71K	0.03%	85
2019 Q1	$90K	Sell	401 -32	-7%	-$8.47K	0.05%	85
2018 Q4	$111K	Buy	433 +12	+3%	+$2.93K	0.07%	77
2018 Q3	$117K	Buy	+421	New	+$129K	0.08%	72
2018 Q2	–	Sell	-362	Closed	-$88K	–	73
2018 Q1	$88K	Hold	362	–	–	0.06%	71
2017 Q4	$109K	Sell	362 -10	-3%	-$2.78K	0.07%	71
2017 Q3	$98K	Sell	372 -10	-3%	-$2.89K	0.07%	62
2017 Q2	$101K	Buy	382 +20	+6%	+$5.01K	0.07%	64
2017 Q1	$130K	Hold	362	–	–	0.1%	62
2016 Q4	$104K	Buy	+362	New	+$112K	0.08%	58

Other funds holding TXMD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

CWG

C WorldWide Group Copenhagen, Denmark $4.66B AUM 11.67% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Managed Account Services's TXMD Position: Q3 2021 in Review

Managed Account Services held its TherapeuticsMD (TXMD) position steady in Q3 2021 at 392 shares worth $15K. The position accounts for ﹤0.01% of the portfolio, ranked #106.

Managed Account Services first reported a position in TXMD in Q4 2016 and has held it in 19 quarters since. The position peaked at $130K in Q1 2017. 149 funds tracked by Wall St. Rank hold TXMD as of Q3 2021.

Managed Account Services held 392 shares of TherapeuticsMD worth $15K as of Q3 2021.
Managed Account Services left its TherapeuticsMD share count unchanged in Q3 2021.
TherapeuticsMD made up ﹤0.01% of Managed Account Services's portfolio in Q3 2021, its #106 holding.
Managed Account Services first reported a position in TherapeuticsMD in Q4 2016 and has held it in 19 quarters since.
Managed Account Services's TherapeuticsMD position peaked at $130K in Q1 2017.
149 funds tracked by Wall St. Rank held TherapeuticsMD as of Q3 2021.

Based on Managed Account Services's 13F filing for Q3 2021, filed 9 Nov 2021.